» कंपनी समाचार » The vaccine has arrived, महामारी कब खत्म होगी?

टीका आ गया है, महामारी कब खत्म होगी?

2020-12-02

टीका आ गया है, महामारी कब खत्म होगी?

टीकों की प्रगति ने लोगों को नई आशा दी है. अगला स्वाभाविक प्रश्न है: वैक्सीन आ गई है, महामारी कब खत्म होगी? हमारा जीवन कब सामान्य होगा?

दिसंबर 02, 2020
स्रोत: New York Chinese Information Network

Following Pfizer/BioNTech’s application for an emergency use authorization (यूएसए) for its vaccine to the U.S. Food and Drug Administration (एफडीए) last week, today (नवंबर 30) American biotech company Moderna also applied for its vaccine The same EUA application was filed. Both the final data of the Pfizer/BioNTech vaccine trial and the interim data of the Moderna trial showed approximately 95% effectiveness. This is an impressive achievement far beyond the predictions of most scientists.

The progress of vaccines has given people who are in the midst of the epidemic see new hope. अगला स्वाभाविक प्रश्न है: महामारी कब खत्म होगी? हमारा जीवन कब सामान्य होगा?

It is also based on the good news of vaccines that former US FDA Commissioner Dr. Scott Gottlieb told CNBC that the US is currently facingthe last round of infection surge”, “I believe the situation in 2021 It will get better”. But the problem is that Americans will need to work hard to survive the next two or three months. Otherwise, according to his prediction, by the end of 2020, one-third of the people may be infected with the new crown, which means that there will be thousands of people. Wan’s people died before the dawn.

The next question is vaccination

Pfizer will be able to produce 50 million doses by the end of this year, two doses of vaccine can immunize 25 million people, and the first batch of vaccines will be supplied to the United States. The company has begun working with US airlines, regulatory agencies, and airports to discuss the possibility of delivering vaccines in large quantities. The Wall Street Journal reported that the first batch of Pfizer vaccines had arrived in Chicago from Belgium on Friday.

Moderna expects that by the end of this year, it will be able to supply 20 million doses to the United States, which will also enable 10 million people to be immunized.

Since the initial supply of vaccines is limited and cannot be delivered to remote areas of the United States, it is estimated that once the vaccine is approved in mid-December, medical staff in large and medium-sized cities and elderly people in nursing homes will be the first group to be vaccinated. The Centers for Disease Control and Prevention (CDC) plan will have the staff of five federal agencies, including the Bureau of Prisons, the Department of Defense, the State Department, the Indian Health Service, and the Veterans Health Administration. These agencies will also give priority to those over 70 years old The elderly and employees with basic diseases are vaccinated. The CDC said, उदाहरण के लिए, in the State Council, a 70-year-old diplomat who needs to travel overseas frequently should belong to the first echelon to obtain the vaccine.

The model created by scientists from the Centers for Disease Control and Prevention calculated that the actual number of infections was about 8 times the reported number. Then the actual number of new coronavirus infections in the United States at the end of September was close to 53 दस लाख. It is currently possible Nearly 100 दस लाख, the infected population reached 29%.

This estimate is similar to the conclusion of a study by the Massachusetts Institute of Technology (MIT). MIT estimates that as of October 30, 2020, the cumulative number of cases and deaths are 8.5 times and 1.4 times that of the official report, क्रमश:. Over time, the fatality rate from infection has dropped significantly.

the epidemic end when wil the epidemic end

शायद आपको भी पसंद हो

  • श्रेणियाँ

  • हाल के पोस्ट

  • टैग

    नाक का स्वाब निर्वात पम्प ट्यूब सैंपलिंग स्वाब नमूना संग्रहण सरवाइकल ब्रश योनि झाड़ू वीटीएम किट स्त्री रोग स्वाब नमूना संग्रह ट्यूब चीन सूती पोंछा टीका नमूना ट्यूब न्यूक्लिक एसिड परीक्षण चिकित्सा सफाई झाड़ू पट्टी नमूना संग्रह स्वाब COVID-19 न्यूक्लिक एसिड टेस्ट लार कलेक्टर चिकित्सक सीएचजी एप्लीकेटर नासॉफिरिन्जियल स्वाब रक्त संग्रहण ट्यूब कीटाणुनाशक ऐप्लिकेटर वायरस सैंपलिंग ट्यूब ग्रीवा झाड़ू एचपीवी फोम झाड़ू सैंपलिंग ट्यूब वैक्यूम रक्त संग्रह ट्यूब कोविड-19 परीक्षण नॉवल कोरोना वाइरस मेडिकल स्वाब बाँझ झाड़ू वायरस परिवहन माध्यम ऐप्लिकेटर झुंड झाड़ू नासॉफिरिन्जियल स्वैब परिवहन माध्यम डीएनए महामारी मौखिक स्वाब ओरोफरीन्जियल स्वैब कंठ फाहा
  • हमारे बारे में


    मेडिको टेक्नोलॉजी कंपनी, लिमिटेड. चीन में चिकित्सा आपूर्ति की एक पेशेवर निर्माता है, हम नायलॉन फ्लॉक स्वैब का उत्पादन और बिक्री करते हैं, वीटीएम किट, लार संग्रह किट और सीएचजी स्वैब & ऐप्लिकेटर.

  • संपर्क करें

    पता: कमरा 201, 301 और 401 बिल्डिंग ए नंबर 10, बाओ लंबी 5 वीं सड़क, टोंगल समुदाय, बाओलोंग स्ट्रीट, लोंगगैंग जिला,शेन्ज़ेन, गुआंग्डोंग, चीन.

    वेब: www.medicoswab.com

    फ़ोन नंबर: +86 0755-28997664

    ईमेल: info@medicoswab.com